Dr. Benjamin Greenbaum co authored the paper, “Neoantigen quality predicts immunoediting in survivors of pancreatic cancer” along with Marta Łuksza et al. in the journal Nature .  In it they investigate how 70 human pancreatic cancers evolved over 10 years. They find that, despite having more time to accumulate mutations, rare long-term survivors of pancreatic...Read More